ExpressGraft-C9T1 Skin Tissue as a Treatment of Diabetic Foot Ulcers

NCT02657876 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetic Foot Ulcer
Non-healing Wound

Interventions

BIOLOGICAL: ExpressGraft-C9T1 Skin Tissue

Sponsor

Stratatech, a Mallinckrodt Company

Collaborators

[object Object]